Masafumi MATSUO

Person

Kobe-shi, JP

People

Patents Grantslast 30 patents

Information Patent Grant
Therapeutic agent for glycogen storage disease type IA
- Patent number 11,958,878
- Issue date Apr 16, 2024
- Daiichi Sankyo Company, Limited
- Makoto Koizumi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acid drug for inducing skipping of variant exon of CD44 gen...
- Patent number 10,174,319
- Issue date Jan 8, 2019
- KNC LABORATORIES CO., LTD.
- Masafumi Matsuo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
ENA nucleic acid pharmaceuticals capable of modifying splicing of m...
- Patent number 9,657,050
- Issue date May 23, 2017
- Daiichi Sankyo Company, Limited
- Masafumi Matsuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ENA nucleic acid pharmaceuticals capable of modifying splicing of m...
- Patent number 9,657,049
- Issue date May 23, 2017
- Orphan Disease Treatment Institute Co., Ltd.
- Masafumi Matsuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Readthrough inducing agent and drug for treating genetic disease ca...
- Patent number 9,358,246
- Issue date Jun 7, 2016
- Microbial Chemistry Research Foundation
- Ryoichi Matsuda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prophylactic or ameliorating agent for genetic diseases
- Patent number 9,241,929
- Issue date Jan 26, 2016
- Masatoshi Hagiwara
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ENA nucleic acid pharmaceuticals capable of modifying splicing of m...
- Patent number 9,243,026
- Issue date Jan 26, 2016
- Daiichi Sankyo Company, Limited
- Masafumi Matsuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ENA nucleic acid drugs modifying splicing in mRNA precursor
- Patent number 8,624,019
- Issue date Jan 7, 2014
- Daiichi Sankyo Company, Limited
- Masafumi Matsuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ENA nucleic acid drugs modifying splicing in mRNA precursor
- Patent number 7,902,160
- Issue date Mar 8, 2011
- Nonprofit Organization Translational Research Organization of Duchenne Muscul...
- Masafumi Matsuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical composition for treatment of Duchenne muscular dystr...
- Patent number 6,727,355
- Issue date Apr 27, 2004
- JCR Pharmaceuticals Co., Ltd.
- Masafumi Matsuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Medicament for treatment of Duchenne muscular dystrophy
- Patent number 6,653,467
- Issue date Nov 25, 2003
- JCR Pharmaceutical Co., Ltd.
- Masafumi Matsuo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Pharmaceutical composition for treatment of duchenne muscular dystr...
- Patent number 6,653,466
- Issue date Nov 25, 2003
- JCR Pharmaceuticals Co., Ltd.
- Masafumi Matsuo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Membrane-bound metalloprotease and soluble secreted form thereof
- Patent number 6,548,284
- Issue date Apr 15, 2003
- JCR Pharmaceuticals Co., Ltd.
- Masafumi Matsuo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
NUCLEIC ACID MEDICINE EXPRESSING SPLICING VARIANT OF MYOSTATIN
- Publication number 20240229036
- Publication date Jul 11, 2024
- KNC Laboratories Co., Ltd.
- Masafumi MATSUO
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Application
NUCLEIC ACID MEDICINE EXPRESSING SPLICING VARIANT OF MYOSTATIN
- Publication number 20240132893
- Publication date Apr 25, 2024
- KNC Laboratories Co., Ltd.
- Masafumi MATSUO
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Application
ANTISENSE OLIGONUCLEOTIDE INDUCING EXON SKIPPING OF ANGIOTENSIN CON...
- Publication number 20230272403
- Publication date Aug 31, 2023
- KNC Laboratories Co., Ltd.
- Masafumi MATSUO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEIC ACID DRUG SUPPRESSING PRODUCTION OF MYOSTATIN GENE MRNA
- Publication number 20220220478
- Publication date Jul 14, 2022
- KNC Laboratories Co., Ltd.
- Masafumi MATSUO
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Application
INHIBITION OF MYOSTATIN SIGNAL BY MYOSTATIN SPLICE VARIANT-DERIVED...
- Publication number 20220135637
- Publication date May 5, 2022
- KNC Laboratories Co., Ltd.
- Masafumi MATSUO
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Application
MYOCARDIAL DYSFUNCTION THERAPEUTIC AGENT
- Publication number 20210207136
- Publication date Jul 8, 2021
- DAIICHI SANKYO COMPANY, LIMITED
- Masafumi MATSUO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
THERAPEUTIC AGENT FOR GLYCOGEN STORAGE DISEASE TYPE IA
- Publication number 20200407394
- Publication date Dec 31, 2020
- DAIICHI SANKYO COMPANY, LIMITED
- Makoto KOIZUMI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NUCLEIC ACID DRUG FOR INDUCING SKIPPING OF VARIANT EXON OF CD44 GEN...
- Publication number 20170137810
- Publication date May 18, 2017
- KNC LABORATORIES CO., LTD.
- Masafumi MATSUO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENA NUCLEIC ACID PHARMACEUTICALS CAPABLE OF MODIFYING SPLICING OF m...
- Publication number 20160002636
- Publication date Jan 7, 2016
- DAIICHI SANKYO COMPANY, LIMITED
- Masafumi MATSUO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Readthrough Inducing Agent and Drug for Treating Genetic Disease Ca...
- Publication number 20150005249
- Publication date Jan 1, 2015
- MICROBIAL CHEMISTRY RESEARCH FOUNDATION
- Ryoichi Matsuda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENA NUCLEIC ACID PHARMACEUTICALS CAPABLE OF MODIFYING SPLICING OF m...
- Publication number 20140316123
- Publication date Oct 23, 2014
- DAIICHI SANKYO COMPANY, LIMITED
- Masafumi Matsuo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Prophylactic or Ameliorating Agent for Genetic Diseases
- Publication number 20130102644
- Publication date Apr 25, 2013
- Masatoshi Hagiwara
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENA NUCLEIC ACID PHARMACEUTICALS CAPABLE OF MODIFYING SPLICING OF m...
- Publication number 20130090465
- Publication date Apr 11, 2013
- Masafumi MATSUO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Readthrough Inducing Agent and Drug for Treating Genetic Disease Ca...
- Publication number 20130005953
- Publication date Jan 3, 2013
- Ryoichi MATSUDA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENA NUCLEIC ACID DRUGS MODIFYING SPLICING IN mRNA PRECURSOR
- Publication number 20110046360
- Publication date Feb 24, 2011
- Nonpro. Org. Trans. Res. Org. of Duch. Musc. Dys.
- Masafumi MATSUO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ena nucleic acid drugs modifying splicing in mrna precursor
- Publication number 20070082861
- Publication date Apr 12, 2007
- Masafumi Matsuo
- Masafumi Matsuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical composition for treatment of Duchenne muscular dystr...
- Publication number 20020055481
- Publication date May 9, 2002
- JCR PHARMACEUTICALS CO., LTD
- Masafumi Matsuo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pharmaceutical composition for treatment of duchenne muscular dystr...
- Publication number 20010056077
- Publication date Dec 27, 2001
- JCR PHARMACEUTICALS CO., LTD
- Masafumi Matsuo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Masafumi MATSUO

Person

Patents Grantslast 30 patents

Therapeutic agent for glycogen storage disease type IA

Nucleic acid drug for inducing skipping of variant exon of CD44 gen...

ENA nucleic acid pharmaceuticals capable of modifying splicing of m...

ENA nucleic acid pharmaceuticals capable of modifying splicing of m...

Readthrough inducing agent and drug for treating genetic disease ca...

Prophylactic or ameliorating agent for genetic diseases

ENA nucleic acid pharmaceuticals capable of modifying splicing of m...

ENA nucleic acid drugs modifying splicing in mRNA precursor

ENA nucleic acid drugs modifying splicing in mRNA precursor

Pharmaceutical composition for treatment of Duchenne muscular dystr...

Medicament for treatment of Duchenne muscular dystrophy

Pharmaceutical composition for treatment of duchenne muscular dystr...

Membrane-bound metalloprotease and soluble secreted form thereof

Patents Applicationslast 30 patents

NUCLEIC ACID MEDICINE EXPRESSING SPLICING VARIANT OF MYOSTATIN

NUCLEIC ACID MEDICINE EXPRESSING SPLICING VARIANT OF MYOSTATIN

ANTISENSE OLIGONUCLEOTIDE INDUCING EXON SKIPPING OF ANGIOTENSIN CON...

NUCLEIC ACID DRUG SUPPRESSING PRODUCTION OF MYOSTATIN GENE MRNA

INHIBITION OF MYOSTATIN SIGNAL BY MYOSTATIN SPLICE VARIANT-DERIVED...

MYOCARDIAL DYSFUNCTION THERAPEUTIC AGENT

THERAPEUTIC AGENT FOR GLYCOGEN STORAGE DISEASE TYPE IA

NUCLEIC ACID DRUG FOR INDUCING SKIPPING OF VARIANT EXON OF CD44 GEN...

ENA NUCLEIC ACID PHARMACEUTICALS CAPABLE OF MODIFYING SPLICING OF m...

Readthrough Inducing Agent and Drug for Treating Genetic Disease Ca...

ENA NUCLEIC ACID PHARMACEUTICALS CAPABLE OF MODIFYING SPLICING OF m...

Prophylactic or Ameliorating Agent for Genetic Diseases

ENA NUCLEIC ACID PHARMACEUTICALS CAPABLE OF MODIFYING SPLICING OF m...

Readthrough Inducing Agent and Drug for Treating Genetic Disease Ca...

ENA NUCLEIC ACID DRUGS MODIFYING SPLICING IN mRNA PRECURSOR

Ena nucleic acid drugs modifying splicing in mrna precursor

Pharmaceutical composition for treatment of Duchenne muscular dystr...

Pharmaceutical composition for treatment of duchenne muscular dystr...